0 Comments
0 Shares
9 Views
0 Reviews
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
ESR1 Mutated Metastatic Breast Cancer Diagnostics Market Growth, Predictable to Witness Sustainable Evolution Analysis By FMINEWARK, DE / April 7, 2026 / The global ESR1 mutated metastatic breast cancer diagnostics market is projected to grow from USD 64.61 million in 2025 to USD 92.92 million by 2035, registering a CAGR of 3.7%. Growth is driven by the rising prevalence of ESR1 mutations in metastatic breast cancer patients, increasing adoption of precision medicine, and advancements in...0 Comments 0 Shares 34 Views 0 Reviews